Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
238 participants
OBSERVATIONAL
2014-04-30
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease
NCT01937221
Retinal Imaging in Neurodegenerative Disease
NCT03233646
Words on the Brain: Can Reading Rehabilitation for Age-Related Vision Impairment Improve Cognitive Functioning?
NCT04276610
Eye Scanning for Safety Driving
NCT06396273
Eye Movement Recording as an Early Differential Diagnostic Tool for Alzheimer/Depression
NCT01434940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AMD controls
No interventions assigned to this group
AMD cases
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\- Vision loss attributable to AMD
Controls
* Age match (± 5 yrs)
* Gender match
* Education match (± 4yrs)
* Normal macular exam
Exclusion Criteria
* Other significant eye pathology
* Mod/severe dementia
* Communication barrier that precludes testing
Controls
* Other significant eye pathology
* Mod/severe dementia
* Communication barrier that precludes testing
MRI subset
* Devices or material incompatible with 3.0 Tesla MRI
* Conditions that may interfere with interpretation of fMRI (e.g. history of stroke, brain tumor or previous brain surgery; psychoactive medications; seizure disorder)
* Claustrophobia
* Left-handed
* Body weight \> 300 lbs
* Pregnant women
50 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heather Whitson, MD
Role: PRINCIPAL_INVESTIGATOR
Duke Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University Medical Center
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00046073
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.